Arcturus Therapeutics Holdings (ARCT) Net Income Growth (5y) (2023 - 2026)

Arcturus Therapeutics Holdings (ARCT) Net Income Growth (5y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Arcturus Therapeutics Holdings 194.97 Mn -16.41 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 12.89%
Dec 31, 2025 1.32%
Sep 30, 2025 8.47%
Jun 30, 2025 1.78%
Mar 31, 2025 -8.27%
Dec 31, 2024 -22.64%
Sep 30, 2024 1.95%
Jun 30, 2024 -97.56%
Mar 31, 2024 -32.77%
Dec 31, 2023 -75.11%
Sep 30, 2023 -30.09%
Jun 30, 2023 -39.15%